ReviewFrontiers in neuroscience2017
Remodeling Functional Connectivity in Multiple Sclerosis: A Challenging Therapeutic Approach.
Review in Frontiers in neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03999788 (Clinical Relevance of miR-142-3p as Potential Biomarker of Synaptopathy in Multiple Sclerosis), which is not on this map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Clinical Relevance of miR-142-3p as Potential Biomarker of Synaptopathy in Multiple Sclerosis
Who cites it
13 citing papers in PubMed, 25 citations in OpenAlex.
- Motor Sequence Learning across Multiple Sessions Is Not Facilitated by Targeting Consolidation with Posttraining tDCS in Patients with Progressive Multiple Sclerosis.Neural plasticity · 2021Trial
- Theory of Mind and Information Processing Speed in Multiple Sclerosis: Associations With Personality Traits.Brain and behavior · 2026Article
- Effect of Aerobic Exercise versus Non-Invasive Brain Stimulation on Cognitive Function in Multiple Sclerosis: A Systematic Review and Meta-Analysis.Brain sciences · 2024Review
- Graph theoretical approach to brain remodeling in multiple sclerosis.Network neuroscience (Cambridge, Mass.) · 2023Article
- Anatomical and functional visual network patterns in progressive multiple sclerosis.Human brain mapping · 2022Article
- No Changes in Functional Connectivity After Dimethyl Fumarate Treatment in Multiple Sclerosis.Neurology and therapy · 2022Article
- A model for interrogating the clinico-radiological paradox in multiple sclerosis: Internuclear ophthalmoplegia.European journal of neurology · 2021Article
- Estimated connectivity networks outperform observed connectivity networks when classifying people with multiple sclerosis into disability groups.NeuroImage. Clinical · 2021Article
- Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study.Frontiers in immunology · 2021Observational
- Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis.Frontiers in aging neuroscience · 2021Article
- The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice.Frontiers in neuroscience · 2020Article
- Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity.International journal of molecular sciences · 2019Review
- Compromised tDCS-induced facilitation of motor consolidation in patients with multiple sclerosis.Journal of neurology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurons in the central nervous system are organized in functional units interconnected to form complex networks. Acute and chronic brain damage disrupts brain connectivity producing neurological signs and/or symptoms. In several neurological diseases, particularly in Multiple Sclerosis (MS), structural imaging studies cannot always demonstrate a clear association between lesion site and clinical disability, originating the "clinico-radiological paradox." The discrepancy between structural damage and disability can be explained by a complex network perspective. Both brain networks architecture and synaptic plasticity may play important roles in modulating brain networks efficiency after brain damage. In particular, long-term potentiation (LTP) may occur in surviving neurons to compensate network disconnection. In MS, inflammatory cytokines dramatically interfere with synaptic transmission and plasticity. Importantly, in addition to acute and chronic structural damage, inflammation could contribute to reduce brain networks efficiency in MS leading to worse clinical recovery after a relapse and worse disease progression. These evidence suggest that removing inflammation should represent the main therapeutic target in MS; moreover, as synaptic plasticity is particularly altered by inflammation, specific strategies aimed at promoting LTP mechanisms could be effective for enhancing clinical recovery. Modulation of plasticity with different non-invasive brain stimulation (NIBS) techniques has been used to promote recovery of MS symptoms. Better knowledge of features inducing brain disconnection in MS is crucial to design specific strategies to promote recovery and use NIBS with an increasingly tailored approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.